AKT1 and non-small cell lung carcinoma: According to the candidate targets shown in the Fig. 8A, fucosterol may be able to achieve the purpose of treating NSCLC through activating the Ras signaling pathway, PI3K-Akt signaling pathway, ErbB signaling pathway and MAPK signaling pathway to regulate cell proliferation and apoptosis.